Please select an option below to help us tailor your newsletter to best suit your content interests!
In a new article highlighting the importance of inclusive clinical research, we have been recognized as 1 of the 4 inaugural sites of Genentech‘s Advancing Inclusive Research® (AIR) Site Alliance. The article highlights how our research team identified an eligibility requirement in a breast cancer study that was disproportionately excluding Black women. Our team’s feedback helped… Read more »
Join us for Best of ASCO®: Memphis on August 8–9 at the Hilton Memphis for two days of the latest advances in oncology, expert-led education, and 8.5 CME credits — registration is FREE! We’re especially proud that two of our own oncologists will be presenting: 🔹 Dr. Axel Grothey – Non-Colorectal Cancer 🔹 Dr. Jason… Read more »
We are so proud to announce the launch of a groundbreaking clinical study with IceCure Medical, making our network the 1st U.S. clinical site for the company’s ProSense® cryoablation technology. The ChoICE Study will evaluate the use of ProSense® cryoablation in low-risk breast cancer patients, enrolling approximately 400 patients across 30 clinical sites nationwide. This important research… Read more »
Dr. Axel Grothey will present new research at this year’s ESMO – European Society for Medical Oncology – Gastrointestinal Cancer Congress in Munich, Germany, highlighting an innovative approach to improving diagnosis for patients with carcinoma of unknown primary (CUP) and other diagnostically complex cancers. As lead investigator, Dr. Grothey collaborated with West providers Heather Greene,… Read more »
We are proud to announce that West will be the 1st cancer center in the Mid‑South to offer Daraxonrasib, a next‑generation targeted therapy representing one of the most significant advances in pancreatic cancer treatment in years. Daraxonrasib is designed to interrupt key cancer‑driving pathways associated with some of the most aggressive forms of pancreatic cancer. Early clinical data has shown meaningful improvements in tumor response,… Read more »
We’re excited to share that Dr. Michael Doherty, our Director of Interventional Radiology, has been featured in the latest issue of Memphis Health & Fitness magazine! In the feature, Dr. Doherty discusses innovative minimally invasive procedures that can help treat knee pain, back pain, plantar fasciitis, inflammation, and other conditions—often with less downtime and without… Read more »
Join Us for the 2026 Best of ASCO Memphis Conference Join us for the upcoming “2026 Best of ASCO Memphis Conference,” taking place Saturday and Sunday, August 8–9, 2026, at the Hilton Memphis Hotel. This highly anticipated event brings together oncology professionals from across the region for a weekend of collaboration, education, and practical clinical… Read more »
NEW BARTLETT CAMPUS We are excited to announce the expansion of our network with a new Bartlett location, bringing expert surgical care even closer to patients in the surrounding community. This new location is designed with your convenience in mind – making it easier to receive high-quality, specialized care without having to travel far. Patients… Read more »
Join us for the 11th Annual West Oncology Conference — May 16–17, 2026 (in-person with on-demand access). This accredited meeting delivers practice-changing updates in breast, genitourinary, hematologic, gastrointestinal, and lung cancers with expert faculty, interactive panels, molecular tumor boards, and networking opportunities. Highlights include CAR-T preparation, MRD in myeloma/AML, HER2 management, AI in oncology, and… Read more »
Dr. Axel Grothey recently authored a powerful column in the Tennessean highlighting the urgent need for colorectal cancer screening across the state. Dr. Grothey sheds light on the state’s high rates of colon cancer diagnoses and deaths, while emphasizing that early detection can dramatically improve outcomes. His column also introduces a promising new FDA-approved blood… Read more »